Letter to the Editor

Periampullary Leiomyosarcoma Presenting with Cutaneous Metastases: A Rare Entity

Authors: Mrinal Pahwa, MS, Mohit Girotra, MD, Archana Rautela, MBBS, Khushboo Goel, MBBS, Saurabh Taneja, MD, Rtika R. Abraham, MD

Abstract

To the Editor:


Leiomyosarcoma (LMS) is a rare malignancy, which arises from smooth muscle cells and comprises less than 10% of all soft tissue sarcomas.1 More than 50% of LMS are uterine in origin, followed by gastrointestinal and retroperitoneal. Though the metastatic potential of visceral LMS is well recognized, its cutaneous metastasis is a particularly rare entity.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Martin RG. Malignant tumors of the small intestine. Surg Clin North Am 1986;66:779–785.
 
2. Blanchard DK, Budde JM, Hatch GF III, et al. Tumors of the small intestine. World J Surg 2000;24:421–429.
 
3. Rao UN, Hanan SH, Lotze MT, et al. Distant skin and soft tissue metastases from sarcomas. J Surg Oncol 1998;69:94–98.
 
4. Ng EH, Pollock RE, Munsell MF, et al. Prog-nostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging. Ann Surg 1992;215:68–77.